Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ESOMEPRAZOLE for Gastrinoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 35 adverse event reports in the FDA FAERS database where ESOMEPRAZOLE was used for Gastrinoma.

Most Reported Side Effects for ESOMEPRAZOLE

Side Effect Reports % Deaths Hosp.
Chronic kidney disease 35,281 46.7% 3,747 3,298
Acute kidney injury 18,678 24.7% 2,504 3,371
Renal failure 14,633 19.4% 2,483 2,645
End stage renal disease 10,231 13.5% 2,190 1,407
Renal injury 9,440 12.5% 832 1,089
Gastrooesophageal reflux disease 4,746 6.3% 119 826
Drug ineffective 4,420 5.8% 30 679
Tubulointerstitial nephritis 4,024 5.3% 530 675
Off label use 3,180 4.2% 171 786
Pain 2,898 3.8% 51 679
Nephrogenic anaemia 2,869 3.8% 508 853
Intentional product misuse 2,852 3.8% 25 494
Nausea 2,590 3.4% 250 908
Death 2,514 3.3% 2,510 197
Rebound acid hypersecretion 2,501 3.3% 373 291

Other Indications for ESOMEPRAZOLE

Gastrooesophageal reflux disease (27,743) Product used for unknown indication (17,549) Dyspepsia (3,546) Gastrointestinal disorder (1,015) Prophylaxis against gastrointestinal ulcer (872) Prophylaxis (747) Gastritis (725) Hiatus hernia (627) Barrett's oesophagus (568) Ulcer (527)

Other Drugs Used for Gastrinoma

RANITIDINE (775) OCTREOTIDE (41) OMEPRAZOLE (29) LANSOPRAZOLE (13) PANTOPRAZOLE (13) FAMOTIDINE (9) EVEROLIMUS (7) LANREOTIDE (5)

Related Pages

ESOMEPRAZOLE Full Profile All Gastrinoma Drugs ESOMEPRAZOLE Demographics ESOMEPRAZOLE Timeline